MOTS-c belongs to a group of peptides encoded within the mitochondrial genome. A 2021 investigation combined experiments on cultured muscle cells and mice with observations in ten healthy young men during exercise. Administered MOTS-c improved some physical-performance measures in mice, while cell experiments explored adaptation to metabolic stress. In the human component, researchers measured naturally occurring MOTS-c in muscle and blood before and after cycling. Levels increased with exercise. The human participants were not given MOTS-c, so this part of the study cannot show whether administration improves human exercise performance.
Research context
Muscle-cell stress responses
Physical performance in mice
Endogenous changes after human exercise
EXPLORE THE EVIDENCE
Studies & research references
Each source identifies what was studied and the limits of its findings. Published research is separate from this product’s batch COA.
MOTS-c administration improved selected performance measures in mice. The human component measured exercise-associated changes in endogenous peptide levels and was not an administration trial.
MOTS-c is currently listed in 10 mg, 40 mg. Select a strength above to see its price, product image and current stock. Listed quantities are supplied specifications, not measured batch results.
Is a COA available for MOTS-c?
1 laboratory report is published for this compound. Match the selected strength and available batch identifiers, and open the original document to check the actual test scope.
A catalogue listing is not a laboratory measurement. Check original documentation for the selected strength and batch before relying on identity, purity or quantity information.